focus -WSS

focus

author：entertainment 2025-09-05 07:02:29 - browse：599

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： A Greenpeace activist is fined for crash

knowledge

explore

WSS

How to ethically and practically extend health care to all

Chris Christie meets with Zelenskyy during Ukraine trip

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Digital health funding stays low as a new reality sets in

Blinken talks high

knowledge

focus

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The a glaring gap in research on serious mental illness and primary care

Supreme Court strikes down use of affirmative action

When waiting feels immoral: Empathy in the emergency department

Apple is now the first public company to be valued at $3 trillion

Britney Spears to release memoir, 'The Woman In Me,' later this year

Trump demands the U.S. pay no more for drugs than other countries … again

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Trump demands the U.S. pay no more for drugs than other countries … again

FDA approves Sage Therapeutics’ rapid

hotspot

Pharma showers House GOP doctor with campaign cash

After half a century, Israel moves to evict squatter from his cave home on the beach

Late stage cancers on the rise after pandemic delayed screenings

How are insurers handling Leqembi and related scans?

Companies helping big Covid

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Wikipedia

knowledge

explore

focus